We encourage you to talk with your healthcare practitioner about your symptoms and what treatment options might best address your individual symptoms.
To learn more, please visit:
About the Study
The HOPE4MCI Alzheimer’s Trial is assessing the efficacy and safety of an investigational medication to determine if it can treat the symptoms associated with Mild Cognitive Impairment due to Alzheimer’s Disease (MCI due to AD) and control further progression leading to the onset of Alzheimer’s dementia.